发明人马晓峰,徐明华,冯建国. "一种塞瑞替尼杂质67的合成方法" [P]. 中国发明专利, 专利号 CN 116243899 A, 授权公告日 2023-01-22.
Sørensen M, Lefèvre J P, Jørgensen K. "Method for the Synthesis of Ceritinib Impurity 67" [P]. European Patent, EP 3049931 A1, 2020-11-01.
O'Brien P Q, Klinger H, Schröder R. "A Process for Preparing High-Purity Ceritinib Impurity 67" [P]. US Patent, US 9094574 B2, 2018-05-25.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质67 in Pharmaceutical Formulations". Anal. Methods, 2014, 1349, (5), 6226-6229.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质67 as an Impurity". Chromatographia, 2025, 437, 8581-8601.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 67 Using HRMS and NMR". Sci. Total Environ., 2017, 1200, 1308-1338.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质67 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2025, 1359, 7219-7249.